Unicycive Therapeutics, Inc. (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

6.48

-0.46 (-6.63%)

Jun 25, 2025, 12:09 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Novel Therapies	675.00K	Log In
Novel Therapies Growth	-29.02%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	675.00K	Log In
United States Growth	-29.02%	Log In